As a COVID-19 vaccine is being distributed, President Donald Trump is taking note of what he sees as a lack of credit for progress. The outgoing president recently spoke to several consultants and associates about how the vaccine may have worked, according to three people familiar with his personal grievances, who may have worked to deny him the opportunity to declare success in infections. This month, the president asked The Daily Beast, a consultant, that the leaders of Pfizer, one of the major vaccine manufacturers, were “Democrats.” “It’s nowhere, I do not know how to respond. When Pfizer announced its vaccine progress last month, Trump flew into a fight after the company said it was not directly involved in the administration’s public-private partnership Operation Warp Speed to develop and distribute COVID vaccines. The president, already annoyed that no vaccine improvement had been announced before the election, told some aides and close associates to go on television and make public statements denying Pfizer’s claims, adding that only two sources could accuse Trump and his team of making progress. “It’s nowhere, I do not know how to respond.” On Friday, White House Chief of Staff Mark Meadows told Stephen Hahn, head of the Food and Drug Administration, that he needed to consider polishing his resume, which was not approved at the end of the day. According to reports, Lawn had summoned the FDA chief to the White House earlier this month, demanding answers as to why the vaccination process was not moving so quickly. Meadows later denied to the Daily Beast that he had been pushed. “Get a new source,” he said at the time. The representation of his speech with the lawns was “false,” he said in a statement. The White House did not comment on the story Friday afternoon. But one campaigner, who works on vaccine production and development, said the mere comment that the White House was applying was that the pressure on the FDA chief on the day the vaccine was introduced was so complex that it fostered distrust in vaccine safety. “It’s not as bad as shooting the FDA in the head,” campaigners said. “But it does nothing but create negative headlines about the effectiveness of the vaccine.” The source said it was not surprising that Trump would use this type of pressure. For months, the trade group’s pre-election advertising campaign has been at odds with Big Pharma over the president’s attack on him for pursuing a policy that insists Medicare should not pay more than the preferred national price for prescription drugs. Trump sought to reduce a deal with a trade group in which he would have abandoned that policy objective in exchange for pharmaceutical companies, cutting drug costs out of pocket and sending cash cards to Medicare beneficiaries. But the deal exploded in fear that these cards would be politicized — in fact, these are called “Trump cards”. The friction has worsened as Trump has become increasingly angry at the speed at which a govt vaccine has been developed and approved. This past week, Trump held a summit to celebrate the pace of Operation Warp. But the announcement came long before invitations were sent to key stakeholders. When the day came, representatives of Pfizer and Moderna, another company that had recently announced positive vaccine results, refused to show up. Trump’s anger was directed at Han as well. He has been questioning executives for weeks as to why it takes so long for the FDA to approve the final vaccine, and that the White House’s demand is pressuring the commissioner to “do his job,” according to a source with direct knowledge of the president’s request. The FDA for vaccine development has a rigorous and well-established review process that includes numerous clinical trials and numerous data reviews by external consultants. The final confirmation of the effectiveness of a vaccine is precisely designed in such a way as to evoke the belief that it is not colored by political or monetary considerations. But the process does not particularly accommodate the president’s need for speed, praise or credit. This, at this point, seems to be causing problems. “Donald Trump needs to get credit for vaccines. This is a miracle, “the president tweeted Friday morning, quoting a Fox Business Hostel quote as saying,” If it were not for Donald Trump’s personal leadership, we would not be seeing a Pfizer vaccine – and next week, a modern approved vaccine. ” Tweeted in the afternoon. .
Source
